scholarly journals Web-Based Communication Strategies Designed to Improve Intention to Minimize Risk for Colorectal Cancer: Randomized Controlled Trial

JMIR Cancer ◽  
2018 ◽  
Vol 4 (1) ◽  
pp. e2 ◽  
Author(s):  
Carlene Wilson ◽  
Ingrid Flight ◽  
Ian T Zajac ◽  
Deborah Turnbull ◽  
Graeme P Young ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Communication Strategies ◽  
Web Based ◽  
Randomized Controlled

Effects of Web-Based Interventions on Physical Activity and Quality of Life in Colorectal Cancer Survivors: Systematic Review and Meta-Analysis (Preprint)

2021 ◽  
Author(s):  
Ching-Ching Su ◽  
Su-Er Guo ◽  
Ya-Wen Kuo
Keyword(s):  
Quality Of Life ◽  
Physical Activity ◽  
Colorectal Cancer ◽  
Randomized Controlled Trial ◽  
Cancer Survivors ◽  
Controlled Trial ◽  
Web Based ◽  
Randomized Controlled ◽  
Colorectal Cancer Survivors

BACKGROUND Approximately 80% of colorectal cancer survivors have at least one comorbidity. Physical activity (PA) can mitigate the adverse effects of disease treatment, reduce patients’ mortality rate, and improve their quality of life (QoL). However, colorectal cancer survivors generally engage in insufficient PA. The present study proposed that web-based interventions can assist patients with colorectal cancer in improving their PA behavior to induce health-promoting effects, thus positively influencing their QoL. OBJECTIVE To perform a systematic literature review, to employ web-based interventions to improve the PA behavior and QoL of colorectal cancer survivors, and to assess the quality of research articles. METHODS A systematic literature search was performed based on the PRISMA guidelines to compile literature on the influence of web-based interventions on the PA activity and QoL of colorectal cancer survivors. Electronic databases (PubMed, CINAHL, EMBASE, Cochrane Central Register of Controlled Trials, and CEPS) were searched up until July 2020. Additionally, the researchers manually searched for journal articles referenced in the collected literature. Literature quality assessment and data extraction were performed by 3 researchers individually using the Joanna Briggs Institute appraisal tool. RESULTS Among the 438 searched studies, 6 published between 2009 and 2019 met the inclusion criteria. Of these studies, 4 had adopted randomized controlled trial designs and 2 had employed one-group pretest–posttest designs. The collected literature exhibited risk of bias to varying degrees. The overall outcomes revealed that after 6 months of web-based interventions, participants’ performance in PA indicators improved significantly (P = .03). Additionally, a comparison conducted using the European Organization for Research and Treatment of Cancer Quality of Life scale revealed no significant differences between the experiment group, which received 3 months of intervention, and the control group (P = .24). However, a comparison conducted using the Functional Assessment of Cancer Therapy-Colorectal questionnaire indicated a significant difference in QoL indicators between groups (P = .01). CONCLUSIONS Web-based interventions are conducive to improving the PA behavior and QoL of colorectal cancer survivors. Because intervention outcomes may differ based on the intervention time and the assessment tools used, more randomized controlled trial–based clinical research is required to provide suggestions for clinical practice.

scholarly journals Web-Based Communication Strategies Designed to Improve Intention to Minimize Risk for Colorectal Cancer: Randomized Controlled Trial (Preprint)

2017 ◽  
Author(s):  
Carlene Wilson ◽  
Ingrid Flight ◽  
Ian T Zajac ◽  
Deborah Turnbull ◽  
Graeme P Young ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Risk Factors ◽  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Cancer Information ◽  
Free Text ◽  
Age Group ◽  
Access To Information ◽  
Web Based ◽  
Randomized Controlled

BACKGROUND People seek information on the Web for managing their colorectal cancer (CRC) risk but retrieve much personally irrelevant material. Targeting information pertinent to this cohort via a frequently asked question (FAQ) format could improve outcomes. OBJECTIVE We identified and prioritized colorectal cancer information for men and women aged 35 to 74 years (study 1) and built a website containing FAQs ordered by age and gender. In study 2, we conducted a randomized controlled trial (RCT) to test whether targeted FAQs were more influential on intention to act on CRC risk than the same information accessed via a generic topic list. Secondary analyses compared preference for information delivery, usability, relevance, and likelihood of recommendation of FAQ and LIST websites. METHODS Study 1 determined the colorectal cancer information needs of Australians (N=600) by sex and age group (35-49, 50-59, 60-74) through a Web-based survey. Free-text responses were categorized as FAQs: the top 5 issues within each of the 6 cohorts were identified. Study 2 (N=240) compared the impact of presentation as targeted FAQ links to information with links presented as a generic list (LIST) and a CONTROL (no information) condition. We also tested preference for presentation of access to information as FAQ or LIST by adding a CHOICE condition (a self-selected choice of FAQs or a list of information topics). RESULTS Study 1 showed considerable consistency in information priorities among all 6 cohorts with 2 main concerns: treatment of CRC and risk factors. Some differences included a focus on general risk factors, excluding diet and lifestyle, in the younger cohort, and on the existence of a test for CRC in the older cohorts. Study 2 demonstrated that, although respondents preferred information access ordered by FAQs over a list, presentation in this format had limited impact on readiness to act on colorectal cancer risk compared with the list or a no-information control (P=.06). Both FAQ and LIST were evaluated as equally usable. Those aged 35 to 49 years rated the information less relevant to them and others in their age group, and information ordered by FAQs was rated, across all age groups and both sexes, as less relevant to people outside the age group targeted within the FAQs. CONCLUSIONS FAQs are preferred over a list as a strategy for presenting access to information about CRC. They may improve intention to act on risk, although further research is required. Future research should aim to identify better the characteristics of information content and presentation that optimize perceived relevance and fully engage the target audience. CLINICALTRIAL Australian New Zealand Clinical Trials Registry: ACTRN12618000137291; https://www.anzctr.org. au/Trial/Registration/TrialReview.aspx?id=374129 (Archived by WebCite at http://www.webcitation.org/6x2Mr6rPC)

Effectiveness of a web-based medication adherence tool with patient centered communication: Results of a clustered randomized controlled trial (Preprint)

2019 ◽  
Author(s):  
Jan van Lieshout ◽  
Joyca Lacroix ◽  
Aart van Halteren ◽  
Martina Teichert
Keyword(s):  
Randomized Controlled Trial ◽  
Medication Adherence ◽  
Controlled Trial ◽  
Intervention Group ◽  
Control Group ◽  
Community Pharmacies ◽  
Web Based ◽  
Randomized Controlled ◽  
Tailored Interventions ◽  
Increased Risk

BACKGROUND Growing numbers of people use medication for chronic conditions; non-adherence is common, leading to poor disease control. A newly developed web-based tool to identify an increased risk for non-adherence with related potential individual barriers might facilitate tailored interventions and improve adherence. OBJECTIVE To assess the effectiveness of the newly developed tool to improve medication adherence. METHODS A cluster randomized controlled trial assessed the effectiveness of this adherence tool in patients initiating cardiovascular or oral blood glucose lowering medication. Participants were included in community pharmacies. They completed an online questionnaire comprising an assessments of their risk for medication non-adherence and subsequently of barriers to adherence. In pharmacies belonging to the intervention group, individual barriers displayed in a graphical profile on a tablet were discussed by pharmacists and patients at high non-adherence risk in face to face meetings and shared with their general practitioners and practice nurses. Tailored interventions were initiated by the healthcare providers. Barriers of control patients were not presented or discussed and these patients received usual care. The primary outcome was the difference in medication adherence at 8 months follow-up between patients with an increased non-adherence risk from intervention and control group, calculated from dispensing data. RESULTS Data from 492 participants in 15 community pharmacies were available for analyses (intervention 253, 7 pharmacies; control 239, 8 pharmacies). The intervention had no effect on medication adherence (-0.01; 95%CI -0.59 – 0.57; P= .96), neither in the post hoc per protocol analysis (0.19; 95%CI -0.50 – 0.89; P=.58). CONCLUSIONS This study showed no effectiveness of a risk stratification and tailored intervention addressing personal barriers for medication adherence. Various potential explanations for lack of effect were identified. These explanations relate for instance to high medication adherence in the control group, study power and fidelity. Process evaluation should elicit possible improvements and inform the redesign of intervention and implementation. CLINICALTRIAL The Netherlands National Trial Register: NTR5186. Date: May 18, 2015 (http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=5186)

Sign in / Sign up

Export Citation Format

Share Document